Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples

Thyroid

Volumn 21, Issue 2, 2011, Pages 111-118

  Mazeh, Haggi ^a   Mizrahi, Ido ^a   Halle, David ^a   Ilyayev, Nadia ^a   Stojadinovic, Alexander ^b,c   Trink, Barry ^d   Mitrani Rosenbaum, Stella ^a   Roistacher, Marina ^a   Ariel, Ilana ^a   Eid, Ahmed ^a   Freund, Herbert R ^a   Nissan, Aviram ^a,c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c United States Military Cancer Institute   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 221; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADULT; AGED; BIOPSY, FINE-NEEDLE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS;

EID: 79953245747     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0356     Document Type: Article

References (29)

1. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW 2005 Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407-1427. (Pubitemid 41520077)
2. Cognetti DM, Pribitkin EA, Keane WM 2008 Management of the neck in differentiated thyroid cancer. Surg Oncol Clin North Am 17:157-173.
3. Dean DS, Gharib H 2008 Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22:901-911.
4. Galloway JW, Sardi A, Deconti RW, Mitchell WT Jr., Bolton JS 1991 Changing trends in thyroid surgery: 38 years' experience. Am Surg 57:18-20.
5. Mehanna HM, Jain A, Morton RP, Watkinson J, Shaha A 2009 Investigating the thyroid nodule BMJ 13:b733.
6. Rosen J, He M, Umbricht C, Alexander HR, Dackiw AP, Zeiger MA, Libutti SK 2005 A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. Surgery 138:1050-1056.
7. Esquela-Kerscher A, Slack FJ 2006 Oncomirs: microRNAs with a role in cancer. Nat Rev 6:259-269.
8. Negrini M, Ferracin M, Sabbioni S, Croce CM 2007 Micro-RNAs in human cancer: from research to therapy. J Cell Sci 120:1833-1840. (Pubitemid 46979774)
9. Hummel R, Hussey DJ, Haier J 2010 MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 46:298-311.
10. Lee YS, Dutta A 2009 MicroRNAs in cancer. Annu Rev Pathol 4:199-227.
11. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A 2006 MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13:497-508. (Pubitemid 43886672)
12. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A 2005 The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102:19075-19080. (Pubitemid 43049568)
13. Tetzlaff MT, Liu A, Xu X, Master SR, Baldwin DA, Tobias JW, Livolsi VA, Baloch ZW 2007 Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18:163-173. (Pubitemid 351384379)
14. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V, Borbone E, Petrocca F, Alder H, Croce CM, Fusco A 2007 MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14:791-798. (Pubitemid 350074067)
15. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE 2008 MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93:1600-1608. (Pubitemid 351656494)
16. Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T 2008 MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 21: 1139-1146.
17. Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker- Preuss M, Schmid KW 2010 Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 102: 376-382.
18. Cowland JB, Hother C, Grønbaek K 2007 MicroRNAs and cancer. APMIS 115:1090-1106. (Pubitemid 350179476)
19. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM 2006 MicroRNA expression and function in cancer. Trends Mol Med 12:580-587. (Pubitemid 44780201)
20. Zhang B, Pan X, Cobb GP, Anderson TA 2007 MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302:1-12. (Pubitemid 46096921)
21. Bartel DP 2004 MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
22. Ambros V 2003 MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113:673-676.
23. Cho WC 2007 OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6:60.
24. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, Valtieri M, Calin GA, Liu CG, Sorrentino A, Croce CM, Peschle C 2005 Micro-RNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. PNAS 102:18081-18086. (Pubitemid 41798505)
25. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafre' SA, Farace MG 2007 miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282: 23716-23724. (Pubitemid 47311902)
26. Taganov KD, Boldin MP, Chang KJ, Baltimore D 2006 NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. PNAS 103:12481-12486. (Pubitemid 44267285)
27. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC 2008 Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27:5643-5647.
28. Labbaye C, Spinello I, Quaranta MT, Pelosi E, Pasquini L, Petrucci E, Biffoni M, Nuzzolo ER, Billi M, Foa' R, Brunetti E, Grignani F, Testa U, Peschle C 2008 A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol 10:788-801. (Pubitemid 351927708)
29. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR 2009 Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 69:1279-1283.